By Katie Hunt, CNN Scientists have created tiny living robots from human cells that can move around in a lab dish and may one day be able to help heal wounds or damaged tissue, according to a new study. A team at Tufts University and Harvard University’s Wyss...

by Joanne S. Eglovitch - Regulatory Focus The US Food and Drug Administration (FDA) has issued final guidance describing its process for recognizing voluntary consensus standards (VCS) to spur the development of regenerative medicine therapies (RMTs) evaluated within...

By Susan Buckles - Mayo Clinic During clinical rotations in medical school, Kianna Nguyen encountered many patients with liver failure and was struck by a grim reality: Their only hope was a transplant. The shortage of donor organs and therapeutic options was at once...

By Drug Target Review Immunotherapy, the promising therapy which harnesses the power of the body’s immune response to target cancer cells, may be advanced by a new minifridge bioreactor developed by researchers at Washington State University. This bioreactor can...

By UNSW Newsroom The 'Trpzip' material will reform after being squished, fractured, or after being expelled from a syringe. Photo: UNSW Sydney Scientists at UNSW Sydney have created a new material that could change the way human tissue can be grown in the lab and used...

By Waterloo News People who have experienced significant muscle damage have new hope thanks to Evolved.Bio, a startup that has developed innovative technology that can regenerate muscle tissue in a highly effective way. Other biotech companies use natural or synthetic...

by Felix Myhill - RegMedNet Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer. Allogeneic cell therapies differ from autologous cell...

By Mayo Clinic's Discovery's Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The team also found...

By Gina Kolata - The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the...

By News Medical Life Sciences Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in...